Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Kinginvestoron Sep 04, 2018 3:03pm
44 Views
Post# 28560652

RE:RE:RE:ISOL uplisting won't happen

RE:RE:RE:ISOL uplisting won't happenWho is leading 10 feet into a marathon means zero which is my point. You bet on your pony and I'll bet on mine. We might both be wrong but it is to soon to gloat about anything from either one in terms of "world leading revenue"
StockLemon1 wrote: You're right, the market is young. With that said, why invest in ISOL when you can invest in The World Leader in CBD, CWEB?! It's a no brainer. CWEB has better revenues, a trusted name, and best of all, it has great management. 

The numbers don't lie. 

CWEB $17.2 Million US revenues or $22.6 Million Canadian in one quarter!

How about ISOL? Oh yeah, it's halted. Yikes! A projected $10 Million Canadian? LOLZ CWEB is beyond ISOL's league. 

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities